The interaction between Ca2+ sensors STIM1 and STIM2 and Ca2+ channel-forming protein ORAI1 is a crucial element of store-operated calcium entry (SOCE) in non-excitable cells. However, the molecular mechanism of SOCE in neurons remains unclear. We addressed this issue by establishing the presence and function of STIM proteins. Real-time polymerase chain reaction from cortical neurons showed that these cells contain significant amounts of Stim1 and Stim2 mRNA. Thapsigargin (TG) treatment increased the amount of both endogenous STIM proteins in neuronal membrane fractions. The number of YFP-STIM1/ORAI1 and YFP-STIM2/ORAI1 complexes was also enhanced by such treatment. The differences observed in the number of STIM1 and STIM2 complexes under SOCE conditions and the differential sensitivity to SOCE inhibitors suggest their distinct roles. Endoplasmic reticulum (ER) store depletion by TG enhanced intracellular Ca2+ levels in loaded with Fura-2 neurons transfected with YFP-STIM1 and ORAI1, but not with YFP-STIM2 and ORAI1, which correlated well with the number of complexes formed. Moreover, the SOCE inhibitors ML-9 and 2-APB reduced Ca2+ influx in neurons expressing YFP-STIM1/ORAI1 but produced no effect in cells transfected with YFP-STIM2/ORAI1. Moreover, in neurons transfected with YFP-STIM2/ORAI1, the increase in constitutive calcium entry was greater than with YFP-STIM1/ORAI1. Our data indicate that both STIM proteins are involved in calcium homeostasis in neurons. STIM1 mainly activates SOCE, whereas STIM2 regulates resting Ca2+ levels in the ER and Ca2+ leakage with the additional involvement of STIM1.
Citation: Gruszczynska-Biegala J, Pomorski P, Wisniewska MB, Kuznicki J (2011) Differential Roles for STIM1 and STIM2 in Store-Operated Calcium Entry in Rat Neurons. PLoS ONE 6(4): e19285. https://doi.org/10.1371/journal.pone.0019285
Editor: David Holowka, Cornell University, United States of America
Received: December 29, 2010; Accepted: March 25, 2011; Published: April 26, 2011
Copyright: © 2011 Gruszczynska-Biegala et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by funds from a Polish-German grant (S001/P-N/2007/01, 01GZ0713, JK), from the European Union's Seventh Framework Programme HEALTH-PROT (REG-POT229676, JK), and from a Polish Ministerial grant (1900/B/P01/2010/39, JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Store-operated calcium entry (SOCE), also referred to as capacitative calcium entry (CCE), is a phenomenon that has been well characterized in non-excitable cells. In these cells, the Ca2+ signal usually originates from the induction of metabotropic receptors, leading to the production of IP3 by plasma membrane-located phospholipase and release of Ca2+ from intracellular stores by activity of IP3 receptors. This early stage is followed by SOCE, which relies on extracellular Ca2+ influx through the SOC channels present in the plasma membrane (PM) and is tightly regulated by Ca2+ concentration in the endoplasmic reticulum (ER) , . This influx allows refilling of the ER with Ca2+ ions after their IP3-dependent release to the cytoplasm , . The known proteins involved in this process are sensors of Ca2+ levels in the ER, including STIM1 and STIM2 , , and the Ca2+ channel-forming protein ORAI1 in the plasma membrane , , . The interaction between STIMs and ORAI is a crucial element of calcium homeostasis in non-excitable cells and leads to the formation of complexes visible in fluorescent microscopy as so-called “puncta” (reviewed by ). Calcium entry into the cytoplasm is replenished in the ER by the activity of the Ca2+ adenosine triphosphatase (ATPase) of sarco/endoplasmic reticulum (SERCA) pump, which refills emptied ER stores , , .
STIM1 and STIM2 are integral type I membrane proteins localized in the ER , although a fraction of STIM1 can also be present in the PM , . The N-terminal parts of both STIMs facing the ER lumen contain of EF-hand-type Ca2+-binding domains. STIM2 essentially differs from STIM1 in the C-terminal fragment. STIM1 has been identified as an essential controller of SOCE , , but reports on the role of STIM2 in the SOCE process have been inconsistent. Data show that STIM2 is an inhibitor of SOCE initiated by STIM1 , . Other data show that STIM2, in the absence of STIM1, may be responsible for SOCE initiation as a result of even minor changes in the ER , , . Thus, even in non-excitable cells, the function of STIM proteins has not yet been fully established.
In the case of neuronal cells, in which the main sources of extracellular Ca2+ influx are ion channels for neurotransmitter receptors and voltage-dependent Ca2+ channels , the mechanism of SOCE has only recently become a subject of intensive research , , , . Understanding the mechanism of neuronal SOCE is important with regard to disturbances in calcium homeostasis observed in neurodegenerative diseases (reviewed by , ). Some studies indeed indicate that SOCE dysfunction, which is accompanied by changes in the expression of Ca2+ sensor proteins, may be a cause of some pathologies. For example, in cells with mutated presenilin, which is responsible for early-onset familial Alzheimer's disease, reduced SOCE and impaired STIM2 protein expression were observed .
Few studies have addressed the question of the physiological significance of STIM proteins in neurons. Hasan's group showed that ORAI and dSTIM mediated Ca2+ influx and Ca2+ homeostasis in Drosophila neurons . Nieswandt's group questioned the presence of STIM1 in mouse neurons and claimed that STIM2 regulates SOCE in these cells . Using STIM1 or STIM2 knockout mice, they also presented data showing that STIM2 plays a key role in hypoxic neuronal cell death. In contrast, we demonstrated detailed immunolocalization of STIM1 protein in neurons of mouse brain . The STIM1 antibodies we used did not stain neurons in the sections of the STIM1 knockout embryonic brains obtained from Nieswandt's group. The additional characteristic of STIM1 in neurons performed Keil and co-authors . We also showed, for the first time, that puncta-like co-localization of YFP-STIM1 and ORAI1 appeared upon depletion of Ca2+ stores in cultured rat neurons . However, the YFP-STIM1(D76A) constitutively active mutant concentrates in puncta even without depletion of neuronal Ca2+ stores, and it forces ORAI1 redistribution to those puncta. These observations indicate that STIM1 may play a role in neurons. Recently, one report showed that STIM1 can inhibit L-type voltage-gated Ca2+ channels in neurons . Thus, the role of STIM proteins in neurons appears to be more complicated than originally thought.
In the present work, we show that STIM1 and STIM2 play roles in calcium homeostasis in neurons by analyzing both endogenous proteins in nontransfected cells and overexpressed proteins in transfected cells. We report that cultured cortical neurons exhibit SOCE and that STIM1 and STIM2, despite their high sequence similarity and analogous-based domain structures, play distinct roles in this pathway. Based on our data, we postulate that STIM1 is the major SOCE signal transmitter in neurons, whereas STIM2 has primary responsibility for equilibrium calcium homeostasis.
Stim1 and Stim2 mRNA is present in neurons
The issue of Stim1 gene expression in neurons has been controversial , , . We employed quantitative real-time polymerase chain reaction (PCR) with TaqMan primers and probes to analyze the levels of Stim1 and Stim2 expression in primary cultures of cortical and hippocampal neurons and in cortical astrocytes. The purity of the neuronal and astrocytic cultures was verified by analyzing the expression of specific cell type markers: Map2 for neurons, Gfap for astrocytes, and Aif for microglia (Figure 1A). High levels of Map2 and low levels of Gfap were detected in neuronal cultures, whereas in astrocytic cultures, the level of Gfap, but not Map2, was high. Aif was not detected in any of the cultures. We report that in astrocytic cultures and both neuronal cultures, similar levels of Stim1 mRNA were detected. The level of Stim2 in neurons was approximately two-fold higher than in astrocytes (Figure 1B).
mRNA was isolated from primary cultures of neurons and astrocytes. TaqMan primers and probes were used to quantify specific mRNA levels. (A) The Gfap astrocytic marker and Map2 neuronal marker are differentially expressed in cultures of cortical neurons (Cx), hippocampal neurons (Hip) and astrocytes (Astro), confirming the purity of the cultures. The expression was related to the Gapdh level set as 1 for every culture, using the 2−dCT formula (dCT = CTtarget − CTGapdh; CT is the cycle threshold). (B) Stim1 and Stim2 are expressed in neurons of the cortex (Cx) and hippocampus (Hip) and in cortical astrocytes (Astro). The expression was related to Gapdh as above. (C) The actual number of Stim1 and Stim2 mRNA molecules in 20 ng of RNA isolated from cortical neurons was quantified using a standard curve with serial dilutions of cloned Stim1 and Stim2. (D) The actual number of Stim1 and Stim2 mRNA molecules in laser-dissected hippocampal neurons was quantified as above.
We then calculated the actual number of Stim1 and Stim2 mRNA molecules in the analyzed neuronal samples. Quantification was based on the standard curve obtained with serial dilutions of cloned fragments of rat Stim1 and Stim2 cDNA. This analysis revealed about 9500 copies of Stim1 and 17500 copies of Stim2 mRNA in 20 ng of total RNA extracted from cortical neuronal cultures (Figure 1C). To obtain the exact number of mRNA copies per cell, we used total RNA from laser-dissected hippocampal neurons. We found 65 copies of Stim1 and 307 copies of Stim2 mRNA in 50 hippocampal neurons (Figure 1D). Our data demonstrate that both Stim2 and Stim1 are expressed in neurons.
The amount of endogenous STIMs in membrane subfractions from TG-treated neurons is increased
Recent studies have reported that STIM proteins function as ER Ca2+ sensors in non-excitable cells , . To determine whether endogenous STIMs might act as Ca2+ sensors also in cultured neurons and whether they can respond to a change in ER Ca2+ levels, we examined the effect of TG and the SOCE inhibitor ML9 on their recruitment. We first determined whether the observations with the presence of Stim1 and Stim2 mRNA in neurons can be confirmed by studying endogenous proteins expressed in cultured neurons. To achieve this goal, we isolated membrane and cytosolic fractions from neurons cultured under various calcium conditions, separated them by sodium-dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and performed immunoblotting (Figure 2A). The blots containing cytosolic and membrane proteins from untreated cortical neurons were analyzed for the presence of markers with molecular weight characteristics for selected proteins, such as p-Cadherin (PM marker), calnexin (ER marker), actin, GAPDH (cytosolic markers), STIM2, STIM1, and ORAI1. The immunoblots showed that the cytosolic protein fraction was devoid of PM and ER membranes, whereas the membrane protein fraction contained both p-Cadherin and calnexin and a small amount of actin and GAPDH. Figure 2A shows that ORAI1 and both STIMs are present in membranes from cortical neurons and absent from the cytosolic fraction. During subsequent experiments the cytosolic and membrane fractions were isolated from neurons cultured in Ca2+-containing medium (−/−), from neurons that were transferred to low EGTA-containing medium and treated with thapsigargin (TG; +/−), and from neurons to which the SOCE inhibitor ML9 was added for 5 min after incubation with TG (+/+). The blots were immunostained with STIM1, STIM2, ORAI1, p-Cadherin and actin antibodies and developed by chemiluminescence (Figure 2B). The immunoblotting data revealed an increased amount of endogenous STIMs in membranes from TG-treated neurons. ML9 inhibited such an increase in a slightly greater extent for STIM2 (p<0.001) than for STIM1 (p<0.01) (Figure 2B). The stable level of ORAI1 in the membrane fractions confirms the specificity of redistribution of endogenous STIMs to the PM. To confirm the inhibitory activity of ML9, the intracellular level of Ca2+ ions was measured using a Fura-2 indicator (Figure 2C). In cortical neurons incubated in EGTA-containing medium, TG treatment followed by transfer to a medium containing CaCl2 in the millimolar range induced Ca2+ influx via SOC channels. The subsequent incubation of cells in ML9 inhibited SOCE by approximately 70%. Thus, the data show that the intracellular distribution of both STIM1 and STIM2 in nontransfected neurons is sensitive to the level of Ca2+ in the ER and the SOCE inhibitor (Figure 2), demonstrating that they have the ability to function as SOCE sensors.
(A) Immunoblots of selected marker proteins demonstrate high separation efficiency for subcellular compartments of neurons on cytosolic (C) and membrane (M) fractions. Proteins were analyzed using the anti-pan Cadherin (plasma membrane), anti-STIM2, anti-Calnexin (ER membrane), anti-STIM1, anti-actin (cytosolic), anti-GAPDH (cytosolic), and anti-ORAI1 antibodies. Notice that STIM and ORAI1 proteins are present only in the membrane fraction. (B) Neurons were incubated for 10 min with 2 mM Ca2+ (left, −/−), 2 µM TG in 0.5 mM EGTA (middle, +/−), or 2 µM TG in 0.5 mM EGTA followed by the addition of Ca2+ in the presence of ML9 for 5 min (right, +/+). The cells were then subjected to fractionation into cytosolic and membrane fractions, and proteins were analyzed by immunoblotting using anti-STIM1, anti-STIM2, anti-ORAI1, anti-p-Cadherin and anti-actin (loading controls) antibodies. Blots were developed using chemiluminescence. Only membrane subfractions are shown. The image shows the results from one representative experiment. Bars indicate mean ± SD from at least three separate experiments. STIM1 or STIM2 bands were normalized to the level of loading control p-Cadherin for each immunoblot. (C) Effect of ML9 on SOCE of nontransfected neurons after restoration of extracellular Ca2+. ML9 was added 5 min after the readdition of 2 mM CaCl2. Raw data are shown. The trace represents the average response of cells measured on a single coverslip from two independent experiments.
YFP-STIM1 and YFP-STIM2 form puncta with ORAI1 in response to TG or Ca2+ chelator
To better understand the role of STIM proteins, we compared their ability to form puncta in cultured cortical neurons co-transfected with plasmids encoding either YFP-STIM1 and ORAI1 or YFP-STIM2 and ORAI1. This allowed us to directly correlate intracellular Ca2+ levels with the number of STIMs and ORAI1 complexes. Twenty-four hours after transfection, cells were transferred to a medium with low EGTA and treated with TG to deplete Ca2+ stores. This induced a change in fluorescence distribution in the cells from dispersed in control cells incubated with 2 mM Ca2+ (Figure S1, upper panels) to aggregated after TG treatment (Figure S1, middle panels). We developed a method for puncta counting and found that depletion of Ca2+ from ER stores by the presence of TG increased the number of STIM1-ORAI1 puncta more than nine-fold, whereas the number of STIM2-ORAI1 puncta increased less than two-fold, which was not statistically significant (Figure 3). This indicated, that STIM1 is a major sensor of ER Ca2+ levels during SOCE. The function of STIM1 in neurons being different from STIM2 was also concluded when the yellow fluorescent protein (YFP) fluorescence of STIM protein redistribution was analyzed in transfected neurons transferred to a medium with high EGTA without TG (Figure S1, bottom panels). In YFP-STIM1 cells, the number of puncta increased approximately six-fold, which was slightly less than in the presence of TG-containing medium but still statistically significant (p<0.001). In YFP-STIM2 cells, the number of puncta under identical conditions significantly increased four-fold (p<0.001) (Figure 3). This was a two-fold increase compared with the number observed in the presence of TG, indicating that under high EGTA conditions, STIM2 became activated and STIM1 became inhibited. These observations suggest that STIM1 is likely involved in TG-induced SOCE, and STIM2 is mostly active after EGTA-driven depletion of extracellular Ca2+. The latter leads to calcium homeostasis breakdown and the induction of constitutive calcium entry mechanism to compensate for Ca2+ leakage into the extracellular space.
Number of STIMs-ORAI1 puncta calculated per µm2 of PM area in neurons. Data were obtained from images of neurons co-expressing ORAI1 and YFP-STIM1 (green bars) or YFP-STIM2 (red bars) in the presence of 2 mM extracellular Ca2+ before store depletion, 10 min following treatment with 2 µM TG in 0.5 mM EGTA or 2 mM EGTA alone. The confocal images were analyzed using ImageJ software. Data are expressed as the average of at least 25 cells for each of the transfection conditions. ***p<0.001, compared with control (cells maintained in 2 mM Ca2+); ns, not significant (ANOVA). Bars indicate mean ± SD from at least three separate experiments.
Co-expression of YFP-STIM1 with ORAI1 activates SOCE after TG-induced ER depletion
The differential participation of STIM1 and STIM2 in puncta formation led us to determine their effects on intracellular Ca2+ levels. Cortical neurons were loaded with the Fura-2 Ca2+ indicator in 2 mM CaCl2-containing medium, washed, and transferred to a 0.5 mM EGTA medium to initiate measurements. TG was then added. After 390 s, the medium was changed to 2 mM CaCl2 with continuous detection of Fura-2 signals. The peaks appearing after the exchange of medium were proportional to the number of open SOC channels (Figure 4A). The data in Figure 4B are expressed as the Delta Ratio, which is defined here as the difference between the F340/F380 ratio at the peak obtained as a result of the extracellular Ca2+ addition and the average F340/F380 ratio detected just before the Ca2+ addition. The Delta Ratio values in these experiments were approximately 1.3 for nontransfected cells (closed triangles) and approximately 1.4 for cells transfected with empty YFP vector (open triangles). This difference was not statistically significant (p>0.5) (Figure 4B). Thus, the transfection procedure itself and YFP expression did not have significant effects on the membrane state or on the level of SOCE. Surprisingly, the transfection of neurons with either YFP-STIM1 or YFP-STIM2 alone led to inhibition of SOCE to a Delta Ratio value of approximately 0.5 (Figure 4A, green and red open circles, respectively), and this effect was statistically significant (Figure 4B). However, co-expression with ORAI1 (green closed circles) enhanced SOCE approximately four-fold compared with cells transfected with YFP-STIM1, which was well above the level observed in control cells (triangles). Co-expression of ORAI1 in cells with YFP-STIM2 enhanced SOCE less than two-fold compared with cells transfected only with YFP-STIM2, which was still below the level observed for control cells (Figure 4B). These data show a good correlation between the number of puncta observed in Figure 3 and the extent of SOCE (Figure 4) and indicate that STIM1 plays a major role in SOCE after TG-induced ER depletion in neurons.
(A) Averaged traces from 15–20 cells per trace from at least three experiments of intracellular Ca2+ (F340/F380) levels obtained by ratiometric Fura-2 analysis of neurons overexpressing YFP-STIM1 ± ORAI1, YFP-STIM2 ± ORAI1, YFP, or nontransfected (NT). Measurements were started in a buffer supplemented with 0.5 mM EGTA, which was then replaced by a buffer with 0.5 mM EGTA and 2 µM TG. Finally, 2 mM CaCl2 was added to the medium to detect Ca2+ ion entry. F340/F380 values beginning just before the addition of TG were normalized to the same values (1). (B) Summary data showing the maximum TG-induced Ca2+ ion influx in neurons described in (A). Data are expressed as the Delta Ratio (± SD), which was calculated as the difference between the peak F340/F380 ratio after extracellular Ca2+ was added and its level immediately before the addition of Ca2+. ***p<0.001, compared with control (NT); ns, not significant (ANOVA).
SOCE inhibitors differentiate Ca2+ influx in TG-treated transfected neurons with either STIM1 or STIM2
To further explore the difference between the modes of action of the STIM proteins, we analyzed the level of SOCE in the presence of ML9 (Figure 5A) or 2-APB, another SOCE inhibitor (Figure 5B). ML9 or 2-APB was added before TG treatment to the cells incubated in low EGTA-containing medium, and their concentrations were maintained during the experiments. The effect of ML9 on TG-evoked SOCE was highly effective in nontransfected neurons and significantly lowered its maximum (Figure 5A and C). 2-APB, however, had little effect in nontransfected control cells (Figure 5B and C). In transfected cells, the inhibitory effect of SOCE inhibitors depended on the type of overexpressed STIM protein. ML9 treatment reduced the strength of SOCE two-fold in cells co-transfected with YFP-STIM1 and ORAI1 (p<0.001) but had no significant effect on cells expressing YFP-STIM2 and ORAI1 (Figure 5A and C). 2-APB had the same effect on co-transfected cells, inhibiting cells with STIM1 but not with STIM2 (Figure 5B and C). Thus, the effect of these drugs can be differentiated if Ca2+ influx is induced by STIM1 or STIM2. The data confirm that STIM1 protein is involved in TG-induced SOCE because its Ca2+ influx is sensitive to both SOCE inhibitors. However, STIM2 protein appears to be less important because its involvement in Ca2+ influx is insensitive to these inhibitors.
(A–B) Cortical neurons were co-transfected with YFP-STIM1 and ORAI1 or YFP-STIM2 and ORAI1 or nontransfected (NT). Experiments were performed as described in Figure 4, but (A) 100 µM ML9 or (B) 50 µM 2-APB was added before store depletion with TG in the presence of inhibitors. Ca2+ (2 mM) was then added to assess SOCE. Each trace represents the average response of cells measured on a single coverslip from three independent experiments. F340/F380 values beginning just before the addition of TG were normalized to the same values (1). (C) The average increase in Ca2+ entry observed after the addition of 2 mM CaCl2 to transfected or nontransfected cells in the absence or presence of the SOCE inhibitors from experiments performed as described in (A–B). The data show the peak of the F340/F380 ratio after extracellular Ca2+ was added. ***p<0.001; ns, not significant (ANOVA). Error bars represent the standard error from three independent experiments.
Spontaneous store repletion occurs to a higher extent with YFP-STIM2 cells than YFP-STIM1 cells
The average cytoplasmic resting Ca2+ level depends on the set of proteins with which the cells were transfected (Figure 6A). The cells expressing either YFP-STIM1 or YFP-STIM2 alone (open green and open red circles, respectively) had lower resting Ca2+ levels than nontransfected cells (blue triangles), whereas cells co-expressing YFP-STIM2/ORAI1 had a much higher level of resting Ca2+ (closed red circles vs. blue triangles). The difference was statistically significant (p<0.001). In contrast, YFP-STIM1/ORAI1 transfectants showed similar resting levels without any significant difference compared with nontransfected cells (Figure 6A, closed green circles vs. blue triangles). Subsequent incubation of cells in a high EGTA-containing medium led to a slow decrease in intracellular free Ca2+ ions to similar levels in all analyzed cell types. The highest decrease (and the only one that was statistically significant, p<0.001) was observed in neurons co-transfected with YFP-STIM2/ORAI1 (Figure 6A and B) because those cells had the highest resting level of free Ca2+ before the medium exchange. The exchange of the medium to the one with the original Ca2+ concentration induced constitutive calcium entry in nontransfected cells as well as in double transfectants (YFP-STIM1/ORAI1 and YFP-STIM2/ORAI1) (Figure 6A and C), after which cytoplasmic free Ca2+ levels returned to resting levels characteristic of cells expressing particular proteins (Figure 6A). Cells transfected with STIM1 or STIM2 alone did not develop the peak Ca2+ signal, but their free cytoplasmic Ca2+ levels slowly increased back to the original levels (Figure 6A). The peak observed in nontransfected cells was much shorter and lower than in both double transfectants. The peaks of the Ca2+ response were quite similar in YFP-STIM1/ORAI1 and YFP-STIM2/ORAI1 neurons. However, the subsequent plateau phase, which reflects integrated Ca2+ influx, was much higher in YFP-STIM2/ORAI1 neurons than in YFP-STIM1/ORAI1 neurons (Figure 6A and D). The above data confirm that STIM1 and STIM2 differentially participate in the regulation of resting Ca2+ levels and show that they differentially contribute to the replenishment of Ca2+ stores. An additional argument for their distinct roles came from the experiments in which 50 µM 2-APB was used (Figure 6A and E). In nontransfected and both double-transfected cells, the sole treatment with 2-APB evoked a Ca2+ signal. Although the response of nontransfected cells and YFP-STIM1/ORAI1 transfectants to 2-ABP was rather weak and not significant, YFP-STIM2/ORAI1 transfectants developed well-pronounced Ca2+ transient after 2-APB treatment. This is interesting when comparing these results with the earlier observations that TG-induced SOCE in those transfectants was insensitive to 2-APB (Figure 5B and C). Figure 6 shows that a major role of STIM2 in neurons is the control of ER resting Ca2+ levels and their maintenance by tuning Ca2+ entry. STIM1 may also regulate constitutive calcium entry.
(A) Cytosolic Ca2+ measurements were performed in cells overexpressing YFP-STIM1 ± ORAI1 or YFP-STIM2 ± ORAI1 or in nontransfected (NT) cells. The experiments started in the presence of 2 mM CaCl2, followed by transfer to Ca2+-free medium. A buffer was then supplemented with 2 mM CaCl2 for 5 min to monitor intracellular Ca2+ restoration. Finally, 50 µM 2-APB was added. Raw (not normalized) traces are shown, which represent the average of at least 30–50 cells from two independent experiments. (B) Summary of basal Ca2+ at the beginning of the experiment. Data are shown as the Delta Ratio values, which were calculated as the difference between the F340/F380 ratio after extracellular Ca2+ was removed and its maximum level at the beginning of the experiment. (C–D) Analysis of constitutive calcium entry in transfected cortical neurons. Traces were normalized to 1 and are shown as a Supplementary Material (Figure S2A). (C) The average increases in Ca2+ entry (peak Ca2+ rise) observed after the addition of 2 mM CaCl2 to transfected cells compared with nontransfected cells are shown. (D) Statistical evaluation of the integrated Ca2+ responses (area under the curve [AUC]) is shown. (E) Effect of 2-APB on Ca2+ responses (peak Ca2+ rise). Traces normalized to 1 are shown as Supplementary Material (Figure S2B). The average Ca2+ responses to 50 µM 2-APB in 2 mM Ca2+ in cells transfected or nontransfected are shown. (B–E) *p<0.05, ***p<0.001, compared with control; ns, not significant (ANOVA). Bars indicate mean ± SD from at least 30–50 cells measured in two independent experiments.
In the present study, we examined the functions of STIM1 and STIM2 in the process of SOCE. We found that under conditions of ORAI1 overexpression in cortical neurons, STIM1 is the main activator of TG-induced SOCE, whereas STIM2 regulates basal luminal Ca2+ levels and activates the constitutive calcium entry with the additional involvement of STIM1. Our findings solve some of the crucial issues related to the mechanism of SOCE in neurons.
Berna-Erro et al., using reverse transcription PCR performed on material isolated by microscopy laser capture from hippocampal neurons, found Stim2 bands on electrophoretic gels, but no band for Stim1 was detected . The authors claimed that Stim1 is expressed in other cells than in neurons. The present study showed that cortical and hippocampal neurons express both Stim mRNA using real-time PCR and specific TaqMan primers and probes. We also used cDNA from 50 laser-captured neurons. The difference between our data and the results of Berna-Erro et al. can be explained by the different PCR protocols and methods of product identification. They analyzed the products of PCR on electrophoretic gels. Unclear is with which cycle the band of Stim2 was obtained and whether the PCR reaction can be considered quantitative. We monitored the PCR reaction during the exponential phase and also applied absolute quantification to calculate the exact copy number of Stim1 and Stim2 molecules per 50 cells for laser-captured neurons or 20 ng for scraped material from cultures. According to our data, the levels of Stim1 expression in neurons and astrocytes are similar.
We also showed that Ca2+ store depletion induces an increase in the association of STIM1 and STIM2 with the membrane fraction. Taking into account that STIMs have been found only in the membranes, one of the possibilities is that ER vesicles are pelleted with the increasing efficiency as a result of STIM aggregation and its interaction with ORAI present in plasma membrane. Another explanation for this result could be that the recovery of ER membrane is altered under the conditions of TG stimulation. However, this seems unlikely since the level of calnexin, ER membrane marker, did no change as a result of TG treatment (not shown). In turn, the addition of 100 µM ML9 reduced the level of both STIMs in the membrane fraction and inhibited endogenous SOCE. These results are consistent with data obtained from non-excitable cells by Smyth et al., in which the rearrangements of STIM proteins was a reversible process, and the inhibition of SOCE by ML9 was attributable to the reversal of STIM localization .
We observed a strong STIM1-dependent signal and the dependence of SOCE on its inhibitors, similar to other cell types. Both inhibitors (ML9 and 2-APB) are widely accepted as affecting SOCE, although their precise mechanisms of action are unclear. ML9 was assumed to regulate SOCE by means of cytoskeleton modulation, but Putney's group showed that ML9 may block the activity of other kinases to inhibit SOCE . Nevertheless, ML9 and 2-APB strongly inhibited the signal in YFP-STIM1/ORAI1 and endogenous STIM-ORAI1 in nontransfected neurons, demonstrating that SOCE occurred.
From the discovery of the role of STIM proteins in store-operated Ca2+ signal formation , , STIM1 protein is clearly a key player in SOCE. The recent report showed that STIM1 can inhibit L-type voltage-gated Ca2+ channels in neurons , indicating that the mechanisms of calcium homeostasis in neurons are more complex than anticipated, and additional links might exist between voltage-dependent Ca2+ channels and SOCE. We propose that STIM1 acts as a controller of Ca2+ leakage. Our results show that after incubation of neurons with high EGTA-supplemented buffer, constitutive calcium entry was increased in YFP-STIM1/ORAI1 neurons. Thus, it is not surprising that we observe under such conditions an increase in the number of YFP-STIM1 and ORAI1 complexes, similarly as in case of YFP-STIM2 and ORAI1 puncta. In non-excitable HEK293 cells STIM1 and ORAI1 co-expression had only very modest effects on Ca2+ leak , . Moreover, puncta of STIM1 were shown to be formed in HeLa cells, however much less rapidly than STIM2 puncta, when ER Ca2+ stores were slowly depleted by EGTA treatment . Also, it has been suggested that the STIM1 can create two types of puncta: “resting” oligomers in cells with replenished Ca2+ stores or higher-order oligomers in store-depleted cells . Thus, it seems that STIM1 might response to EGTA treatment in non-excitable cells, but with a very modest sensitivity. It is therefore possible that in rat cortical neurons it has higher sensitivity to EGTA.
The role of STIM2 protein was much more elusive and difficult to interpret. Our results show the relative inability of STIM2 protein to form puncta after complete store depletion, which is believed to be necessary for SOCE to occur . However, overexpressed STIM2 can build into STIM1 puncta , acting as an inhibitor of SOCE, which strongly suggests completely different modes of action of this protein. On the other hand, the inhibitory effect of STIM2 on SOCE may depend on the construct concentration. Putney's group demonstrated that STIM2 overexpression at a lower plasmid concentration did not inhibit TG-activated Ca2+ entry and thus no longer behaved like a partial agonist . Nonetheless, we did not observe statistically significant inhibitory influence of ML-9 or 2-APB on SOCE activated by complete store depletion in transfected cells. However, from the results shown in nontransfected cells, it is difficult to exclude the scenario in which STIM2 also contributes to endogenous SOCE in neurons. Especially that in Figure 2B we show that ML9 inhibits STIM2 enrichment in membranes after TG treatment.
Another possible role of STIM2 protein is the regulation of resting ER Ca2+ level , . In the resting cell, the ER Ca2+ load is in equilibrium with cytoplasmic free Ca2+ levels, and STIM2 also influences cytoplasmic Ca2+ load. Indeed, we observed a strong increase in resting cytoplasmic Ca2+ levels in YFP-STIM2/ORAI1 co-transfectants. This result may reflect the YFP or overexpression-induced aggregation of YFP-STIM2 and ORAI1 constructs. However, the elevated baseline we observe only in the case of YFP-STIM2 + ORAI 1 but not of YFP-STIM1 + ORAI1 transfectants, what makes this possibility implausible. Another important finding is that YFP-STIM2/ORAI1 does not inhibit basal Ca2+ entry, as in case of SOCE induced by TG but, contrariwise, largely increase the Ca2+ level, suggesting that STIM2 protein significantly interferes with ORAI1 but only with a slight decrease in Ca2+ level in the ER. As previously reported , STIM2 has lower ER Ca2+ sensitivity than STIM1 and therefore STIM2 translocates to puncta with ORAI1 and activates constitutive calcium influx upon smaller decreases in ER Ca2+ concentration compared with STIM1. Extended incubation in the EGTA-containing medium leads to a decrease in cytoplasmic Ca2+ levels and presumably also slowly empties ER Ca2+ stores. The hypothesis of STIM2 as an equilibrium regulator is strongly supported by kinetic studies of STIM oligomerization performed by Ikura's group , who showed approximately 70-fold slower aggregation of STIM2 compared with STIM1. This result is further corroborated by the effect described for 2-APB on resting cells. The burst of Ca2+ into the cytoplasm of STIM2-ORAI1 cells after STIM-independent ORAI1 induction attributable to 2-APB binding to the channel was described by Putney's group . Thus, this poorly characterized Ca2+ channel inhibitor, which is believed to be a SOCE blocker, was able to compensate for the increase in resting Ca2+ level evoked by STIM2-ORAI1 co-transfection. Notably, our results showing a stimulatory effect of 50 µM 2-APB on cytosolic Ca2+ levels in STIM2/ORAI1-expressing neurons are consistent with published studies demonstrating a similar effect of 2-APB on cytosolic Ca2+ levels ,  and on ICRAC (Ca2+ release activated current)  in non-excitatory cells. However, this effect is better known than understood.
Some researchers believe, however, that at least in some cell types, such as T-lymphocytes or neurons, STIM2 is responsible for SOCE. Rao's group  showed that STIM2 was able to reconstitute SOCE in STIM1-deficient T-lymphocyte cells, even if STIM1 was the main SOCE regulator in wildtype T-lymphocytes. Nieswandt's group claimed that STIM2, but not STIM1, regulates SOCE in neurons . Overall, we report that cultured cortical neurons exhibit SOCE and that STIM1 and STIM2 play distinct roles in this process. Our results indicate that STIM1 is the main SOCE signal transmitter in neurons, whereas STIM2 is responsible for calcium homeostasis clearly influencing resting luminal Ca2+ levels and activating the constitutive calcium entry. Surprisingly, STIM1 also had an effect on basal Ca2+ leakage. In summary, our data show that machinery of SOCE works in neurons as in non-excitatory cells. However, it still remains unclear if SOCE plays a role of direct neurotransmission modulator or is responsible for indirect neuronal function regulator, what was suggested by Tsim and co-workers , .
Materials and Methods
Primary neuron cultures
The cortical neuron cultures were prepared from 19-day-old embryonic (E19) Wistar rat brains. Animal care was in accordance with the European Communities Council Directive (86/609/EEC). The experimental procedures were approved by the Local Commission for the Ethics of Animal Experimentation no. 1 in Warsaw. Brains were removed from rat embryos and collected in cold Hanks solution supplemented with 15 mM HEPES buffer and penicillin/streptomycin. The cortex was isolated, rinsed three times in cold Hanks solution, and treated with trypsin for 20 min. Tissue was then rinsed in warm Hanks solution and dissociated by pipetting. Primary cortical neurons were plated at a density of either 15×104 per 13 mm glass coverslip or 30×104 per 19 mm glass coverslip coated with laminin (2 µg/ml, Roche) and poly-D-lysine (2 µg/ml, Sigma). Cells cultured in 24-well plates were used for immunofluorescence measurements, whereas cultures on 12-well plates were used for measurements of intracellular Ca2+ accumulation. For immunoblotting, neurons were seeded on poly-D-lysine-coated Petri dishes at 7×106 cells/plate. Neurons were grown in Neurobasal medium (Invitrogen) supplemented with B27 (Invitrogen), 0.5 mM glutamine (Sigma), 12.5 µM glutamate (Sigma), and a penicillin (100 U/ml)/streptomycin (100 µg/ml) mixture (Gibco). Cultures were maintained at 37°C in humidified 5% CO2/95% air. The experiments were performed on 8- to 10-day-old cultures.
Real-time PCR analysis and laser capture microscopy
Scraped material from neuronal and astrocytic cultures (isolated according to ) were lysed in RNA Lysis Buffer RLT. Total RNA was then isolated with an RNeasy Plus Kit (Qiagen). Total RNA from 50 laser-captured neurons was isolated with an RNeasy Micro Kit (Qiagen). The laser capture was performed by Zeiss (http://www.zeiss.de/microdissection). cDNA was synthesized with random hexamer primers and SuperScript III RNase H-Reverse Transcriptase (Invitrogen). The cDNA of 50 dissected cells was preamplified with the TaqMan PreAmp Master Mix Kit (Applied Biosystems) during 10 cycles. Our experimental data showed approximately 250-fold amplification.
The samples were examined by real-time PCR in a 7900HT Real Time PCR System (Applied Biosystems). Commercial TaqMan primers and probes (Applied Biosystems) were used to quantify specific mRNA levels: Gapdh (control), Map2 (neuronal marker), Gfap (astrocytic marker), Stim1, and Stim2. For relative quantification, the results were related to the Gapdh mRNA level set as 1, assuming equal amplification efficiency for each primer pair and using the 2−dCT formula (dCT = CTtarget − CTGapdh; CT is the cycle threshold). For absolute quantification, we used a standard curve with serial dilutions of linearized plasmid with cloned fragments of rat Stim1 and Stim2 cDNA (106-101 molecules). To calculate exact mRNA copy numbers per neuron, we ran 1/250 of the preamplified material, corresponding to the initial material obtained from 50 cells.
A full-length ORAI1 cDNA vector was purchased from Open Biosystems in the pCMV-SPORT6 vector. YFP-STIM1 and YFP-STIM2 constructs were a generous gift from Dr. Tobias Meyer, Stanford University. Cortical neurons grown on 13 mm or 19 mm coverslips were transiently transfected with the aid of Lipofectamine 2000 Reagent (2 µl or 4 µl per well in 24- or 12-well plates, respectively; Invitrogen) according to the manufacturer's protocol. We used ORAI1 cDNA and one of the YFP-STIM constructs (STIM1 or STIM2) at 0.4 µg/0.8 µg of DNA per well for each construct, respectively. As a control, 0.8 µg of YFP cDNA per well was used. The cells were exposed to the mixture of plasmid DNA and Lipofectamine 2000 for 3.5 h in a serum-free culture medium. Afterward, the neurons were returned to saved conditioned Neurobasal supplemented with B27, 0.5 mM glutamine, 12.5 µM glutamate, and penicillin/streptomycin. The experimental treatments were initiated 24 h after transfection.
Subcellular fractionation and immunoblotting
For immunoblotting, cortical neurons stimulated for 10 min with 2 mM CaCl2, 2 µM TG in 0.5 mM EGTA, or 2 µM TG in 0.5 mM EGTA followed by 5 min incubation with 100 µM ML-9 were subjected to subcellular fractionations. The cell pellets (∼2×106 cells) were suspended in ice-cold buffer A (250 mM saccharose, 10 mM NaCl, 1.5 mM MgCl2, 0.5 mM DTT, 0.1 mM PMSF, complete EDTA-free protease inhibitors cocktail [Roche] in 10 mM Tris-HCl, pH 7.5) for 30 min and lysed with an insulin syringe (18×). Nuclei were removed by centrifugation at 1,000×g for 10 min at 4°C. The supernatants were subjected to centrifugation at 8,000×g for 10 min to remove the pellets corresponding to the mitochondria fractions. The resulting supernatants, containing cytosolic and membrane proteins, were mixed with 0.11 vol of buffer B (1.4 M NaCl, 30 mM MgCl2, 300 mM Tris-HCl, pH 7.5) and ultracentrifuged at 100,000×g for 1 h at 4°C. The obtained supernatants represented the cytosolic fractions. The membrane proteins (pellets) were extracted with buffer C (15% glycerol, 0.4 M NaCl, 1 mM DTT, 0.1% NP-40, 0.5% Triton, 1 mM PMSF, 20 mM Tris-HCl, pH 7.8 with protease inhibitor mixture), and both fractions were stored at −80°C.
Membrane and cytosolic protein extracts were resolved by 10% SDS-PAGE, transferred to a Protran nitrocellulose membrane (Whatman), and blocked for 2 h at room temperature in TBST (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 0.1% Tween 20) plus 5% dry non-fat milk. Nitrocellulose sheets were then incubated in blocking solution with primary antibodies against STIM1 (ProteinTech Group), STIM2 (Alomone Laboratories), pan- Cadherin (Abcam), calnexin (Sigma), actin (Sigma), GAPDH (Santa Cruz Biotechnology), and ORAI1 (Cell Signaling) at 4°C overnight. The appropriate horseradish peroxidase-conjugated secondary antibody IgG (Sigma) was added at a dilution of 1∶25,000 for 1 h. The peroxidase was detected with enhanced chemiluminescence detection (Amersham Biosciences). The intensity of the bands was measured using a GS-800 Calibrated Densitometer and Quantity One software (Bio-Rad).
Single-cell Ca2+ measurements
Single-cell Ca2+ levels in cortical neurons were recorded using the ratiometric Ca2+ indicator dye Fura-2AM , and imaging was performed as described previously . Cells grown on coverslips were loaded with 2 µM acetoxymethyl (AM) ester of Fura-2 for 30 min at 37°C in a solution containing 145 mM NaCl, 5 mM KCl, 0.75 mM Na2HPO4, 10 mM glucose, 10 mM HEPES (pH 7.4), 1 mM MgCl2, and 0.1% bovine serum albumin (BSA, standard buffer) supplemented with 2 mM CaCl2 at 37°C. After rinsing, coverslips were transferred on a thermostatic chamber that was placed on the stage of a Nikon Diaphot inverted epifluorescence microscope equipped with a fluo×40/1.3 NA oil immersion objective lens. The Ludl Lep MAC 5000 filter wheel system loaded with a Chroma Fura-2 filter set was used for illumination of specimens. Images were acquired using a Andor LucaEMR EMCCD digital camera (Andor Technology). Intracellular Ca2+ levels in individual neuronal cell bodies were calculated after subtracting background fluorescence by measuring the ratio of the two emission intensities for excitation at 340 and 380 nm (F340/F380). The ratio of emissions at 510 nm was recorded every 5 s. Ca2+-free solution instead of CaCl2 contained 0.5 mM EGTA. Data processing was performed using Andor iQ (Andor Technology) and Microsoft Excel software.
For the immunocytochemical experiment, transfected neurons cultured on coverslips and stimulated for 10 min with 2 mM CaCl2, 2 µM TG in 0.5 mM EGTA, or 2 mM EGTA alone were fixed in ice-cold 4% paraformaldehyde (PFA) and 4% sucrose in phosphate-buffered saline (PBS) for 15 min at room temperature. After permeabilization in 0.1% Triton X-100 and blockade with 5% BSA in PBS for 30 min, an antibody against ORAI1 diluted in blocking solution (10% horse serum, 5% sucrose, 2% BSA, and 0.1% Triton X-100 in PBS, pH 7.5) was applied for 2 h at room temperature. The ORAI1 antibody (rabbit) was custom-made against a 15 amino acid peptide (27–41 amino acids) from near the N-terminus of human ORAI1 and affinity-purified (Invitrogen). The staining was detected using anti-rabbit Alexa Fluor 594-conjugated secondary antibody (Molecular Probes) in blocking solution for 45 min at room temperature. To visualize the nuclei of transfected cells, we included the Hoechst 33258 dye (Invitrogen) in the wash for 5 min after the secondary antibody incubation. Coverslips were mounted on slides with Mowiol (5% polyvinyl alcohol [FLUKA], 12% glycerin, 50 mM Tris-HCl, pH 8.5). Images of immunofluorescence were acquired using a TCSSP2 Leica confocal microscope with LCS software.
The number of YFP-STIM1/ORAI1 and YFP-STIM2/ORAI1 puncta within neurons treated with 2 mM CaCl2, 2 µM TG with 0.5 mM EGTA, or 2 mM EGTA alone was determined using NIH ImageJ software. For the analysis, single 0.25 µM thick confocal scans with the largest-diameter cell bodies from the “green” and “red” channels (Figure S1) were applied. The dataset was then deconvoluted, resulting in an improved signal-to-noise ratio and resolution. After deconvolution, a background subtraction was performed followed by the colocalization analysis compiled from both channels. The final processed images were thresholded and masked around the cell periphery. Individual regions corresponding to integrated STIM and ORAI1 puncta were calculated from the masked images by using the particle analysis function. The same setting (size: 0.32–1.62 µm2; circularity: 0–1) was used for all images. Thus, only puncta localized on or near the plasma membrane, which was visualized as a cell contour, were counted.
TG and 2-APB were obtained from Sigma. ML-9 was purchased from Tocris Biosciences. All compounds were dissolved in DMSO. Fura-2 was obtained from Molecular Probes.
Statistical analysis was performed with Prism version 5.02 software (GraphPad, San Diego, CA, USA). All pooled data are expressed as mean ± SD. One-way analysis of variance (ANOVA) was performed to analyze sets of data. Tukey's post hoc test was used to determine statistically significant differences among groups. The degree of significance vs. control is indicated by asterisks: *p<0.05, **p<0.01, ***p<0.001 (ns, not significant, p>0.05).
Confocal analysis of neurons co-transfected with YFP-STIM1 or YFP-STIM2 and ORAI1. Representative overlay images from three independent experiments of neurons co-expressing ORAI1 and YFP-STIM or YFP-STIM2 in the presence of 2 mM extracellular Ca2+ before store depletion (top panels) 10 min following treatment with 2 µM TG in 0.5 mM EGTA (center panels) or 2 mM EGTA alone (bottom panels). The cells expressing YFP-STIM (green) and ORAI1 were then stained with ORAI1 antibody (red). Neurons were analyzed using a Leica confocal microscope, and images represent 0.25 µM thick confocal scans.
Analysis of constitutive calcium entry in transfected cortical neurons. Cytosolic Ca2+ measurements were performed in cells overexpressing YFP-STIM1 ± ORAI1 or YFP-STIM2 ± ORAI1 or in nontransfected (NT) cells. The experiments started in the presence of 2 mM CaCl2, followed by transfer to Ca2+-free medium. A buffer was then supplemented with 2 mM CaCl2 for 5 min to monitor intracellular Ca2+ restoration (A). Finally, 50 µM 2-APB was added (B). The measurements were performed relative to the average [Ca2+]i recorded in Ca2+-free medium (200–400 s of experiment) (A) or relative to the average [Ca2+]i recorded in Ca2+-rich medium (B) normalized to 1. Raw traces are shown in Figure 6A.
We thank Dr. Axel Methner for valuable discussions and sharing with us his group data on STIM proteins, Dr. Tobias Meyer for sharing the YFP-STIM1 and YFP-STIM2 constructs, Ms. Beata Kaza for sharing the astrocyte cultures, Ms. Katarzyna Misztal and Ms. Katarzyna Debowska for helping prepare the primary neuronal cultures, and Drs. Jolanta Baranska, Jacek Jaworski, and Tomasz Wegierski for critically reading the manuscript. We thank ZEISS Labs Munich for the laser dissection of neuronal cultures and cDNA preparations from the collected material.
Conceived and designed the experiments: JGB JK. Performed the experiments: JGB MBW. Analyzed the data: JGB PP MBW JK. Wrote the paper: JGB PP MBW JK.
- 1. Putney JW Jr (1986) A model for receptor-regulated calcium entry. Cell Calcium 7: 1–12.
- 2. Blaustein MP, Golovina VA (2001) Structural complexity and functional diversity of endoplasmic reticulum Ca(2+) stores. Trends Neurosci 24: 602–608.
- 3. Berridge MJ, Irvine RF (1984) Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312: 315–321.
- 4. Berridge MJ, Bootman MD, Roderick HL (2003) Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4: 517–529.
- 5. Liou J, Kim ML, Heo WD, Jones JT, Myers JW, et al. (2005) STIM is a Ca2+ sensor essential for Ca2+-store-depletion-triggered Ca2+ influx. Curr Biol 15: 1235–1241.
- 6. Roos J, DiGregorio PJ, Yeromin AV, Ohlsen K, Lioudyno M, et al. (2005) STIM1, an essential and conserved component of store-operated Ca2+ channel function. J Cell Biol 169: 435–445.
- 7. Feske S, Gwack Y, Prakriya M, Srikanth S, Puppel SH, et al. (2006) A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature 441: 179–185.
- 8. Vig M, Peinelt C, Beck A, Koomoa DL, Rabah D, et al. (2006) CRACM1 is a plasma membrane protein essential for store-operated Ca2+ entry. Science 312: 1220–1223.
- 9. Zhang SL, Yeromin AV, Zhang XH, Yu Y, Safrina O, et al. (2006) Genome-wide RNAi screen of Ca(2+) influx identifies genes that regulate Ca(2+) release-activated Ca(2+) channel activity. Proc Natl Acad Sci U S A 103: 9357–9362.
- 10. Cahalan MD (2009) STIMulating store-operated Ca(2+) entry. Nat Cell Biol 11: 669–677.
- 11. Smyth JT, Dehaven WI, Bird GS, Putney JW Jr (2008) Ca2+-store-dependent and -independent reversal of Stim1 localization and function. J Cell Sci 121: 762–772.
- 12. Putney JW Jr (2007) Recent breakthroughs in the molecular mechanism of capacitative calcium entry (with thoughts on how we got here). Cell Calcium 42: 103–110.
- 13. Varnai P, Hunyady L, Balla T (2009) STIM and Orai: the long-awaited constituents of store-operated calcium entry. Trends Pharmacol Sci 30: 118–128.
- 14. Spassova MA, Soboloff J, He LP, Xu W, Dziadek MA, et al. (2006) STIM1 has a plasma membrane role in the activation of store-operated Ca(2+) channels. Proc Natl Acad Sci U S A 103: 4040–4045.
- 15. Williams RT, Manji SS, Parker NJ, Hancock MS, Van Stekelenburg L, et al. (2001) Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins. Biochem J 357: 673–685.
- 16. Soboloff J, Spassova MA, Hewavitharana T, He LP, Xu W, et al. (2006) STIM2 is an inhibitor of STIM1-mediated store-operated Ca2+ Entry. Curr Biol 16: 1465–1470.
- 17. Bird GS, Hwang SY, Smyth JT, Fukushima M, Boyles RR, et al. (2009) STIM1 is a calcium sensor specialized for digital signaling. Curr Biol 19: 1724–1729.
- 18. Brandman O, Liou J, Park WS, Meyer T (2007) STIM2 is a feedback regulator that stabilizes basal cytosolic and endoplasmic reticulum Ca2+ levels. Cell 131: 1327–1339.
- 19. Parvez S, Beck A, Peinelt C, Soboloff J, Lis A, et al. (2008) STIM2 protein mediates distinct store-dependent and store-independent modes of CRAC channel activation. FASEB J 22: 752–761.
- 20. Putney JW Jr (2003) Capacitative calcium entry in the nervous system. Cell Calcium 34: 339–344.
- 21. Klejman ME, Gruszczynska-Biegala J, Skibinska-Kijek A, Wisniewska MB, Misztal K, et al. (2009) Expression of STIM1 in brain and puncta-like co-localization of STIM1 and ORAI1 upon depletion of Ca(2+) store in neurons. Neurochem Int 54: 49–55.
- 22. Berna-Erro A, Braun A, Kraft R, Kleinschnitz C, Schuhmann MK, et al. (2009) STIM2 regulates capacitive Ca2+ entry in neurons and plays a key role in hypoxic neuronal cell death. Sci Signal 2: ra67.
- 23. Venkiteswaran G, Hasan G (2009) Intracellular Ca2+ signaling and store-operated Ca2+ entry are required in Drosophila neurons for flight. Proc Natl Acad Sci U S A 106: 10326–10331.
- 24. Park CY, Shcheglovitov A, Dolmetsch R (2010) The CRAC channel activator STIM1 binds and inhibits L-type voltage-gated calcium channels. Science 330: 101–105.
- 25. Bojarski L, Herms J, Kuznicki J (2008) Calcium dysregulation in Alzheimer's disease. Neurochem Int 52: 621–633.
- 26. Wojda U, Salinska E, Kuznicki J (2008) Calcium ions in neuronal degeneration. IUBMB Life 60: 575–590.
- 27. Bojarski L, Pomorski P, Szybinska A, Drab M, Skibinska-Kijek A, et al. (2009) Presenilin-dependent expression of STIM proteins and dysregulation of capacitative Ca2+ entry in familial Alzheimer's disease. Biochim Biophys Acta 1793: 1050–1057.
- 28. Skibinska-Kijek A, Wisniewska MB, Gruszczynska-Biegala J, Methner A, Kuznicki J (2009) Immunolocalization of STIM1 in the mouse brain. Acta Neurobiol Exp (Wars) 69: 413–428.
- 29. Keil JM, Shen Z, Briggs SP, Patrick GN (2010) Regulation of STIM1 and SOCE by the ubiquitin-proteasome system (UPS). PLoS One 5: e13465.
- 30. Zhou Y, Mancarella S, Wang Y, Yue C, Ritchie M, et al. (2009) The short N-terminal domains of STIM1 and STIM2 control the activation kinetics of Orai1 channels. J Biol Chem 284: 19164–19168.
- 31. Martin AC, Willoughby D, Ciruela A, Ayling LJ, Pagano M, et al. (2009) Capacitative Ca2+ entry via Orai1 and stromal interacting molecule 1 (STIM1) regulates adenylyl cyclase type 8. Mol Pharmacol 75: 830–842.
- 32. Covington ED, Wu MM, Lewis RS (2010) Essential role for the CRAC activation domain in store-dependent oligomerization of STIM1. Mol Biol Cell 21: 1897–1907.
- 33. Stathopulos PB, Zheng L, Ikura M (2009) Stromal interaction molecule (STIM) 1 and STIM2 calcium sensing regions exhibit distinct unfolding and oligomerization kinetics. J Biol Chem 284: 728–732.
- 34. DeHaven WI, Smyth JT, Boyles RR, Bird GS, Putney JW Jr (2008) Complex actions of 2-aminoethyldiphenyl borate on store-operated calcium entry. J Biol Chem 283: 19265–19273.
- 35. Soboloff J, Spassova MA, Tang XD, Hewavitharana T, Xu W, et al. (2006) Orai1 and STIM reconstitute store-operated calcium channel function. J Biol Chem 281: 20661–20665.
- 36. Wang Y, Deng X, Zhou Y, Hendron E, Mancarella S, et al. (2009) STIM protein coupling in the activation of Orai channels. Proc Natl Acad Sci U S A 106: 7391–7396.
- 37. Oh-Hora M, Yamashita M, Hogan PG, Sharma S, Lamperti E, et al. (2008) Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol 9: 432–443.
- 38. Tung EK, Choi RC, Siow NL, Jiang JX, Ling KK, et al. (2004) P2Y2 receptor activation regulates the expression of acetylcholinesterase and acetylcholine receptor genes at vertebrate neuromuscular junctions. Mol Pharmacol 66: 794–806.
- 39. Siow NL, Choi RC, Xie HQ, Kong LW, Chu GK, et al. (2010) ATP Induces Synaptic Gene Expressions in Cortical Neurons: Transduction and Transcription Control via P2Y1 Receptors. Mol Pharmacol 78: 1059–1071.
- 40. Zawadzka M, Kaminska B (2003) Immunosuppressant FK506 affects multiple signaling pathways and modulates gene expression in astrocytes. Mol Cell Neurosci 22: 202–209.
- 41. Grynkiewicz G, Poenie M, Tsien RY (1985) A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440–3450.